Cargando…
Patient-reported outcomes in patients with hematological relapse or progressive disease: a longitudinal observational study
BACKGROUND: Patients with hematological cancer who experience relapse or progressive disease often face yet another line of treatment and continued mortality risk that could increase their physical and emotional trauma and worsen their health-related quality of life. Healthcare professionals who use...
Autores principales: | Sommer, Mia, Nielsen, Lene Kongsgaard, Nielsen, Lars Børty, Brøndum, Rasmus Froberg, Nielsen, Marlene Maria, Rytter, Anne Stoffersen, Vesteghem, Charles, Severinsen, Marianne Tang, El-Galaly, Tarec Christoffer, Bøgsted, Martin, Grønkjær, Mette, Jørgensen, Lone |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8567661/ https://www.ncbi.nlm.nih.gov/pubmed/34736479 http://dx.doi.org/10.1186/s12955-021-01887-6 |
Ejemplares similares
-
Shared care follow-up of patients with B-cell neoplasms based on nurse-led telephone consultations and PRO-data: a feasibility study from the North Denmark Region
por: Sommer, Mia, et al.
Publicado: (2020) -
Development of a Precision Medicine Workflow in Hematological Cancers, Aalborg University Hospital, Denmark
por: Bødker, Julie S., et al.
Publicado: (2020) -
Implementing the FAIR Data Principles in precision oncology: review of supporting initiatives
por: Vesteghem, Charles, et al.
Publicado: (2019) -
The mutational profile of immune surveillance genes in diagnostic and refractory/relapsed DLBCLs
por: Nesic, Marijana, et al.
Publicado: (2021) -
hemaClass.org: Online One-By-One Microarray Normalization and Classification of Hematological Cancers for Precision Medicine
por: Falgreen, Steffen, et al.
Publicado: (2016)